| Company/Division name | SHL Medical |
| Parent company | SHL Medical |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 165 |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2022 |
| Year reshoring implemented or to be implemented: | 2024 |
| Capital investment ($): | 90 |
| Country(ies) from which reshored: | Switzerland |
| City reshored to: | North Charleston |
| State(s) reshored to: | SC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, Medical Equipment & Supplies |
| Product(s) reshored | medical device injection molding |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
